文献速递肝病

经验丰富的肝病学家使用无创纤维化检测对代谢功能障碍相关脂肪性肝病患者进行纤维化分期的效果如何

How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?
PubMed 文献 · Aliment Pharmacol Ther · 2024-06-11

该研究评估6名经验丰富的肝病学家使用FIB-4、FIB-4+ELF、FIB-4+VCTE及FIB-4+ELF+VCTE对230例MASLD患者进行纤维化分期(F0-2 vs F3-4)与组织学的一致性,并与既定算法方法比较。结果显示肝病学家间一致性良好(κ=0.64-0.70),但与组织学一致性可变(敏感性44%-84%,特异性76%-94%),纯算法方法尤其是FIB-4序贯VCTE倾向于表现更好。

要点

  • 肝病学家使用NIT组合的纤维化分期与组织学一致性可变,敏感性44%-84%,特异性76%-94%。
  • 肝病学家间一致性良好,FIB-4的κ=0.64,FIB-4+ELF的κ=0.70,FIB-4+VCTE的κ=0.69,FIB-4+ELF+VCTE的κ=0.70。
  • 纯算法方法尤其是FIB-4序贯VCTE倾向于比基于NIT的临床医生纤维化评估表现更好。

核心结论

  • 遵循推荐的NIT算法方法进行纤维化分期倾向于比经验丰富的肝病学家进行的不太结构化的基于NIT的临床评估更准确。

研究设计与样本

  • 六名经验丰富的肝病学家独立使用FIB-4、FIB-4+ELF、FIB-4+VCTE和FIB-4+ELF+VCTE对230例MASLD患者进行晚期纤维化(F0-2 vs F3-4)分期,并与组织学和算法方法比较一致性。

主要发现

  • 共纳入230例患者,中位年龄54(22-78)岁,55%为女性,中位FIB-4为1.21(IQR:0.78-1.91),ELF为9.3(IQR:8.6-10.2),VCTE为9.4(IQR:6.3-14.3),41%为F0-1,22%为F2,21%为F3,16%为F4。
  • 原始检测预测组织学F3-4的受试者工作特征曲线下面积分别为FIB-4 0.84、ELF 0.86、VCTE 0.86。
  • 肝病学家间一致性良好:FIB-4的κ=0.64,FIB-4+ELF的κ=0.70,FIB-4+VCTE的κ=0.69,FIB-4+ELF+VCTE的κ=0.70。
  • 个体临床医生纤维化评估与组织学之间的一致性可变,反映在敏感性44%-84%和特异性76%-94%的变异范围内。
  • 当临床医生使用NIT组合时,与组织学的一致性更好,纯算法方法尤其是FIB-4序贯VCTE倾向于比临床医生纤维化评估表现更好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sequential use of non-invasive fibrosis tests (NITs) to identify patients with advanced hepatic fibrosis is recommended. However, it remains unclear how reliable clinicians are staging liver fibrosis using combinations of NITs. AIM: Our aim was to assess concordance between NIT-based 'clinician fibrosis assessment (CFA)' and histology in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and compare this with established algorithmic approaches. METHODS: Six experienced hepatologists independently staged 230 MASLD patients for advanced fibrosis (F0-2 vs F3-4) using FIB-4, FIB-4+ELF, FIB-4+ vibration controlled transient elastography (VCTE; Fibroscan™) and FIB-4+ELF+VTCE. Concordance between histology and CFA or algorithmic approaches were assessed. RESULTS: A total of 230 patients were included (median age 54 [22-78] years; 55% female; median FIB-4 1.21 [IQR: 0.78-1.91]; ELF 9.3 [IQR: 8.6-10.2]; VCTE 9.4 [IQR: 6.3-14.3]; 41% F0-1, 22% F2, 21% F3 and 16% F4). Overall, area under the receiver operator curves for histologic F3-4 for the raw tests were 0.84 for FIB-4, 0.86 for ELF and 0.86 for VCTE. Concordance between the hepatologists was good (FIB4, κ = 0.64; FIB-4+ELF, κ = 0.70; FIB-4+VCTE, κ = 0.69; FIB-4+ELF+VCTE, κ = 0.70). Concordance between individual CFA and histology was variable, which was reflected in variability in sensitivity (44%-84%) and specificity (76%-94%). Concordance with histology was better when clinicians used NIT combinations. Purely algorithmic approaches, particularly sequential use of FIB-4 then VCTE, tended to perform better than the CFA. CONCLUSIONS: Adhering to the recommended algorithmic approaches using NITs to stage fibrosis tended to perform more accurately than less-structured clinician NIT-based assessments conducted by experienced hepatologists.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. McPherson S, Dyson JK, Jopson L, et al. How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease? Aliment Pharmacol Ther. 2024. PMID: 38860621. doi:10.1111/apt.18061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。